These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 30679434)

  • 1. IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling.
    Sheng X; Nenseth HZ; Qu S; Kuzu OF; Frahnow T; Simon L; Greene S; Zeng Q; Fazli L; Rennie PS; Mills IG; Danielsen H; Theis F; Patterson JB; Jin Y; Saatcioglu F
    Nat Commun; 2019 Jan; 10(1):323. PubMed ID: 30679434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): Activation of PERK/eIF2α, IRE1α, ATF6 and calmodulin kinase.
    Merlot AM; Shafie NH; Yu Y; Richardson V; Jansson PJ; Sahni S; Lane DJR; Kovacevic Z; Kalinowski DS; Richardson DR
    Biochem Pharmacol; 2016 Jun; 109():27-47. PubMed ID: 27059255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRE1α-XBP1 pathway promotes melanoma progression by regulating IL-6/STAT3 signaling.
    Chen C; Zhang X
    J Transl Med; 2017 Feb; 15(1):42. PubMed ID: 28222747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer.
    Lin J; Liu H; Fukumoto T; Zundell J; Yan Q; Tang CA; Wu S; Zhou W; Guo D; Karakashev S; Hu CA; Sarma K; Kossenkov AV; Zhang R
    Nat Commun; 2021 Sep; 12(1):5321. PubMed ID: 34493732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer.
    Zhao N; Cao J; Xu L; Tang Q; Dobrolecki LE; Lv X; Talukdar M; Lu Y; Wang X; Hu DZ; Shi Q; Xiang Y; Wang Y; Liu X; Bu W; Jiang Y; Li M; Gong Y; Sun Z; Ying H; Yuan B; Lin X; Feng XH; Hartig SM; Li F; Shen H; Chen Y; Han L; Zeng Q; Patterson JB; Kaipparettu BA; Putluri N; Sicheri F; Rosen JM; Lewis MT; Chen X
    J Clin Invest; 2018 Apr; 128(4):1283-1299. PubMed ID: 29480818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRE1α RNase-dependent lipid homeostasis promotes survival in Myc-transformed cancers.
    Xie H; Tang CH; Song JH; Mancuso A; Del Valle JR; Cao J; Xiang Y; Dang CV; Lan R; Sanchez DJ; Keith B; Hu CC; Simon MC
    J Clin Invest; 2018 Apr; 128(4):1300-1316. PubMed ID: 29381485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.
    Sun H; Lin DC; Guo X; Kharabi Masouleh B; Gery S; Cao Q; Alkan S; Ikezoe T; Akiba C; Paquette R; Chien W; Müller-Tidow C; Jing Y; Agelopoulos K; Müschen M; Koeffler HP
    Oncotarget; 2016 Apr; 7(14):18736-49. PubMed ID: 26934650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRE1α Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8
    Medel B; Costoya C; Fernandez D; Pereda C; Lladser A; Sauma D; Pacheco R; Iwawaki T; Salazar-Onfray F; Osorio F
    Front Immunol; 2018; 9():3050. PubMed ID: 30687308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17-Aminogeldanamycin selectively diminishes IRE1α-XBP1s pathway activity and cooperatively induces apoptosis with MEK1/2 and BRAF
    Mielczarek-Lewandowska A; Sztiller-Sikorska M; Osrodek M; Czyz M; Hartman ML
    Apoptosis; 2019 Aug; 24(7-8):596-611. PubMed ID: 30989459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.
    Liu X; Guo GL; Kong B; Hilburn DB; Hubchak SC; Park S; LeCuyer B; Hsieh A; Wang L; Fang D; Green RM
    Hepatology; 2018 Jul; 68(1):304-316. PubMed ID: 29377207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting the IRE1α Axis of the Unfolded Protein Response Enhances the Antitumor Effect of AZD1775 in TP53 Mutant Ovarian Cancer.
    Xiao R; You L; Zhang L; Guo X; Guo E; Zhao F; Yang B; Li X; Fu Y; Lu F; Wang Z; Liu C; Peng W; Li W; Yang X; Dou Y; Liu J; Wang W; Qin T; Cui Y; Zhang X; Li F; Jin Y; Zeng Q; Wang B; Mills GB; Chen G; Sheng X; Sun C
    Adv Sci (Weinh); 2022 Jul; 9(21):e2105469. PubMed ID: 35619328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acridine Derivatives as Inhibitors of the IRE1α-XBP1 Pathway Are Cytotoxic to Human Multiple Myeloma.
    Jiang D; Tam AB; Alagappan M; Hay MP; Gupta A; Kozak MM; Solow-Cordero DE; Lum PY; Denko NC; Giaccia AJ; Le QT; Niwa M; Koong AC
    Mol Cancer Ther; 2016 Sep; 15(9):2055-65. PubMed ID: 27307600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the IRE1α/XBP1 Endoplasmic Reticulum Stress Response Pathway in
    Zundell JA; Fukumoto T; Lin J; Fatkhudinov N; Nacarelli T; Kossenkov AV; Liu Q; Cassel J; Hu CA; Wu S; Zhang R
    Cancer Res; 2021 Oct; 81(20):5325-5335. PubMed ID: 34548333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRE1α dissociates with BiP and inhibits ER stress-mediated apoptosis in cartilage development.
    Han X; Zhou J; Zhang P; Song F; Jiang R; Li M; Xia F; Guo FJ
    Cell Signal; 2013 Nov; 25(11):2136-46. PubMed ID: 23816533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRE1α Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment.
    Harnoss JM; Le Thomas A; Reichelt M; Guttman O; Wu TD; Marsters SA; Shemorry A; Lawrence DA; Kan D; Segal E; Merchant M; Totpal K; Crocker LM; Mesh K; Dohse M; Solon M; Modrusan Z; Rudolph J; Koeppen H; Walter P; Ashkenazi A
    Cancer Res; 2020 Jun; 80(11):2368-2379. PubMed ID: 32265225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel chemical, STF-083010, reverses tamoxifen-related drug resistance in breast cancer by inhibiting IRE1/XBP1.
    Ming J; Ruan S; Wang M; Ye D; Fan N; Meng Q; Tian B; Huang T
    Oncotarget; 2015 Dec; 6(38):40692-703. PubMed ID: 26517687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRE1α-XBP1s axis regulates SREBP1-dependent MRP1 expression to promote chemoresistance in non-small cell lung cancer cells.
    Xu Y; Gui F; Zhang Z; Chen Z; Zhang T; Hu Y; Wei H; Fu Y; Chen X; Wu Z
    Thorac Cancer; 2024 Oct; 15(29):2116-2127. PubMed ID: 39245881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ER stress and distinct outputs of the IRE1α RNase control proliferation and senescence in response to oncogenic Ras.
    Blazanin N; Son J; Craig-Lucas AB; John CL; Breech KJ; Podolsky MA; Glick AB
    Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9900-9905. PubMed ID: 28847931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of IRE1α through its kinase domain attenuates multiple myeloma.
    Harnoss JM; Le Thomas A; Shemorry A; Marsters SA; Lawrence DA; Lu M; Chen YA; Qing J; Totpal K; Kan D; Segal E; Merchant M; Reichelt M; Ackerly Wallweber H; Wang W; Clark K; Kaufman S; Beresini MH; Laing ST; Sandoval W; Lorenzo M; Wu J; Ly J; De Bruyn T; Heidersbach A; Haley B; Gogineni A; Weimer RM; Lee D; Braun MG; Rudolph J; VanWyngarden MJ; Sherbenou DW; Gomez-Bougie P; Amiot M; Acosta-Alvear D; Walter P; Ashkenazi A
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16420-16429. PubMed ID: 31371506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen modulation of XBP1 is functionally driving part of the AR transcriptional program.
    Stelloo S; Linder S; Nevedomskaya E; Valle-Encinas E; de Rink I; Wessels LFA; van der Poel H; Bergman AM; Zwart W
    Endocr Relat Cancer; 2020 Feb; 27(2):67-79. PubMed ID: 31804970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.